SEC Form 4 · accession 0001209191-19-008776
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandesh Mahatme
Officer — EVP, CFO & CBO
Period of report
Feb 7, 2019
Accepted (ET)
Feb 8, 2019 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 7, 2019 | M | 65,000 | $23.85 | A | 73,649 | D | |
| Common Stock | Feb 7, 2019 | S | 65,000 | $145.00 | D | 8,649 | D | |
| Common Stock | holding | — | — | — | 12,012 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) | $23.85 | Feb 7, 2019 | M | 65,000 | D | Nov 5, 2013 | Nov 5, 2022 | Common Stock | 65,000 | 10,466 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on October 29, 2018. Accordingly, the reporting person had no discretion with regards to the timing of the transaction.